SNX14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.11022302462516E-16 |
Normal-vs-Stage2 |
2.4759999999957E-05 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
4.720200E-01 |
Stage1-vs-Stage3 |
9.035500E-03 |
Stage1-vs-Stage4 |
4.296100E-02 |
Stage2-vs-Stage3 |
5.873800E-02 |
Stage2-vs-Stage4 |
7.583800E-02 |
Stage3-vs-Stage4 |
9.437600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6242562850266E-12 |
Normal-vs-AfricanAmerican |
1.64757096854373E-12 |
Normal-vs-Asian |
2.577600E-03 |
Caucasian-vs-AfricanAmerican |
4.832000E-01 |
Caucasian-vs-Asian |
6.155200E-01 |
AfricanAmerican-vs-Asian |
3.850200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.62925228863742E-12 |
Male-vs-Female |
6.668300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.15703060652595E-12 |
Normal-vs-Age(41-60Yrs) |
6.66133814775094E-16 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
9.20970000262145E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.341900E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.845400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.834000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.016400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.320600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.509600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.829400E-04 |
Normal-vs-Grade 2 |
1.13131726209303E-13 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
3.138000E-01 |
Grade 1-vs-Grade 3 |
2.259600E-02 |
Grade 1-vs-Grade 4 |
1.660890E-03 |
Grade 2-vs-Grade 3 |
2.656600E-03 |
Grade 2-vs-Grade 4 |
2.96099999996802E-06 |
Grade 3-vs-Grade 4 |
4.820500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.77065045853442E-12 |
Normal-vs-ccB subtype |
1.11022302462516E-16 |
ccA subtype-vs-ccB subtype |
5.879000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.6278089987054E-12 |
Normal-vs-N1 |
6.59019999682542E-08 |
N0-vs-N1 |
1.755750E-01 |
|
|